ALS (motor neurone disease): open trials in Germany

10 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT07900672
Register for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System Disorders
Research · Ambulanzpartner Soziotechnologie APST GmbH
Charité - Universitätsmedizin Berlin; Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie; Ambulanz für ALS, SMA und andere Motoneuronerkrankungen, Berlin
Registry updated 2026-10-28
NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Trial Treatment · Phase 3 · Prilenia
ALS outpatient department at Charité - university medicine Berlin, Berlin · ALS Clinic Bonn University, Bonn · Medical School Hannover, ALS Centre, Hanover · University Hospital Jena, Jena · Universitaetsklinikum Schleswig-Holstein - Campus Luebeck, Lübeck · University of Ulm, Ulm
Registry updated 2026-10-27
NCT07674667
FUNCtion ALS: Aiming to Restore UNC13A Function in People Living With ALS
Trial Treatment · Phase 1/2 · Trace Neuroscience, Inc.
Universitätsklinikum Schleswig-Holstein, Lübeck · Tum Klinikum Rechts Der Isar, Munich · University Medical Center Rostock, Rostock
Registry updated 2026-10-14
2025-523111-11-00
A Randomized Phase 1 / 2 Trial Aiming to Restore UNC13A Function in People living with ALS: FUNCtion ALS
Trial Treatment · Phase 1/2 · Trace Neuroscience Inc.
Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Klinikum der Technischen Universitaet Muenchen (TUM Klinikum), Munich · Rostock University Medical Center, Rostock · Universitaetsklinikum Ulm AoR, Ulm
Registry updated 2026-09-22
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 2 · Zydus Therapeutics Inc.
Technische Universitaet Dresden, Dresden · DIAKOVERE Krankenhaus gGmbH, Hanover · Universitaetsklinikum Jena KöR, Jena · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Rostock University Medical Center, Rostock · Universitaetsklinikum Ulm AoR, Ulm
Registry updated 2026-09-01
NCT07142291
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Trial Treatment · Phase 2 · PhenoNet, Inc.
Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie, Berlin · DIAKOVERE Henriettenstift - Klinik für Neurologie und Klinische Neurophysiologie, Hanover · Universitaetsklinikum Schleswig-Holstein, Lübeck
Registry updated 2026-07-23
2025-524002-16-00
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Trial Treatment · Phase 3 · Ferrer Internacional S.A.
Charite Universitaetsmedizin Berlin KöR, Berlin · Universitaetsklinikum Bonn AöR, Bonn · DIAKOVERE Krankenhaus gGmbH, Hanover · Universitaetsklinikum Jena KöR, Jena · Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Universitaetsklinikum Ulm AoR, Ulm
Registry updated 2026-05-14
NCT06877143
Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis
Trial Treatment · University of Ulm
Ulm Universita, Department of Neurology, Ulm
Registry updated 2026-05-06
NCT07100119
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 1 · Eli Lilly and Company
Universitaetsklinikum Schleswig-Holstein AöR, Luebeck · Rostock University Medical Center, Rostock · Universitaetsklinikum Ulm AoR, Ulm
Registry updated 2026-03-06
NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Trial Treatment · Phase 3 · AB Science
Department of Neurology, University of Ulm, Ulm
Registry updated 2025-09-12

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error